Results 131 to 140 of about 58,742 (212)

Micro‐Computed Tomography Based Whole Block Imaging of Asthma‐Associated Airway Remodeling With Mycobacterium avium‐Induced Cavity Formation: 3‐Dimensional Nondestructive Analysis

open access: yesPathology International, Volume 76, Issue 1, January 2026.
Subpleural cavities are characteristic of Mycobacterium avium infections, but the precise route of infection remains unclear. Using merged micro‐computed tomography of multiple formalin‐fixed paraffin‐embedded (FFPE) blocks (merged whole block imaging), we visualized a continuous airway path from the hilum to a subpleural cavity.
Tetsuya Tsukamoto   +10 more
wiley   +1 more source

Primary Humoral Immunodeficiencies and Bronchiectasis in Adults. [PDF]

open access: yesJ Clin Med
Suárez-Cuartín G   +4 more
europepmc   +1 more source

Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients [PDF]

open access: bronze, 2016
Katerina Dimakou   +5 more
openalex   +1 more source

Asthma in Patients With Confirmed Pulmonary Sarcoidosis

open access: yesCanadian Respiratory Journal, Volume 2026, Issue 1, 2026.
Pulmonary sarcoidosis and asthma can present identical symptoms, making clinical evaluation difficult if the two diseases overlap. Diagnostic challenges often lead to either overdiagnosis of asthma in patients with confirmed sarcoidosis or withholding appropriate asthma treatment.
Agata Anna Lewandowska   +9 more
wiley   +1 more source

Efficacy and Safety of Pirfenidone for Mitigation of Interstitial Lung Abnormalities in COVID‐19 Patients: A Meta‐Analysis

open access: yesCanadian Respiratory Journal, Volume 2026, Issue 1, 2026.
Background Although post‐COVID‐19 interstitial lung abnormalities (ILAs) are common, the use of antifibrotic agents to prevent their onset and progression is controversial. We aimed to investigate the effectiveness and safety of pirfenidone to mitigate the onset and progression of ILAs in patients with severe COVID‐19.
Ziyi Zhang   +6 more
wiley   +1 more source

Assessing the Impact of Colchicine on Pulmonary Fibrosis Using Imaging in Patients With Moderate‐to‐Severe COVID‐19 Pneumonia

open access: yesCanadian Respiratory Journal, Volume 2026, Issue 1, 2026.
Objective Pulmonary fibrosis may develop in patients with severe clinical conditions, especially those with high inflammatory indicators. We aimed to investigate the 15‐month follow‐up clinical outcomes in patients with moderate‐to‐severe COVID‐19 pneumonia treated with colchicine and to evaluate its potential in preventing post‐COVID pulmonary ...
Gulhan Ayhan Albayrak   +3 more
wiley   +1 more source

Incidence and Clinical Outcomes of COVID‐19 in Maintenance Hemodialysis Patients in Libya: A Prospective Descriptive Study

open access: yesCase Reports in Infectious Diseases, Volume 2026, Issue 1, 2026.
Hemodialysis patients are at a greater risk of severe disease from COVID‐19. Of the 600 maintenance hemodialysis patients who were regular attendees at the Tripoli Hemodialysis Center in Tripoli, Libya, 12 patients tested positive for SARS‐CoV‐2 infection. The patients’ ages ranged from 48 to 80 years. Three were female (25%), and four (33.3%) reported
Nada Elgriw   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy